+145.1%
MS vs THC
+250.3%
-105.3%
-32.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | THC | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.3% | +0.6% | -0.3% | +0.1% |
| 7D | +1.4% | -0.7% | +2.0% | +1.5% |
| 30D | -0.3% | +1.3% | -1.5% | -0.5% |
| 3M | +0.3% | +64.2% | -64.0% | -10.1% |
| 6M | +31.3% | +8.3% | +23.1% | +28.3% |
| YTD | +24.7% | +33.4% | -8.7% | +15.7% |
| 1Y | +47.9% | +37.7% | +10.2% | +35.7% |
| 3Y | +178.3% | +236.8% | -58.4% | +99.5% |
| All | +145.1% | +250.3% | -105.3% | +74.7% |
Cumulative growth
Daily Returns
Daily percentage return beside THC.
Daily Out/Under-Performance
Portfolio return minus THC return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × THC return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded THC wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling